Trademark: 97690153
Word
SURMOUNT BIO
Status
Pending
Status Code
688
Status Date
Tuesday, December 12, 2023
Serial Number
97690153
Mark Type
4000
Filing Date
Wednesday, November 23, 2022
Published for Opposition
Tuesday, October 17, 2023

Trademark Owner History
elevatebio, LLC - Owner At Publication

Classifications
5 Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a capsule, pill, or liquid that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of cancer, cystic fibrosis, heart disease, and AIDS; Medicinal infusions for treating Cancer, cystic fibrosis, heart disease, and AIDS; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment and prevention of Cancer, cystic fibrosis, heart disease, and AIDS; Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of Cancer, cystic fibrosis, heart disease, and AIDS; Unit dose capsules sold empty for pharmaceutical use
"BIO"

Trademark Events
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 17, 2023
Published For Opposition
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Sep 11, 2023
Approved For Pub - Principal Register
Sep 11, 2023
Examiner's Amendment Entered
Sep 11, 2023
Notification Of Examiners Amendment E-Mailed
Sep 11, 2023
Examiners Amendment E-Mailed
Sep 11, 2023
Examiners Amendment -Written
Aug 16, 2023
Assigned To Examiner
Nov 28, 2022
New Application Office Supplied Data Entered
Nov 26, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24